Trimodality Therapy and Radical Cystectomy Produce Similar Outcomes in MIBC
Trimodality therapy produces similar oncologic outcomes as radical cystectomy in patients with muscle-invasive bladder cancer, a new study suggests.
Trimodality therapy produces similar oncologic outcomes as radical cystectomy in patients with muscle-invasive bladder cancer, a new study suggests.
Blood type may impact immunotherapy outcomes in patients with metastatic RCC, a study suggests.
Researchers say they have identified 4 subtypes of prostate cancer with distinct biological and clinical features, and these subtypes may respond differently to treatment.
The risk of in-hospital death from COVID-19 for patients with cancer differs by sex and cancer type, according to a new study.
Many cancer patients may be treated with drugs that were granted accelerated approval but do not provide a clinical benefit, a study suggests.
Incidence and mortality rates for major genitourinary cancers differ according to sex, race/ethnicity, and geographic region.
Oncology drug approvals in the United States are increasingly supported by single-arm clinical trials, a study suggests.
Black cancer patients are less likely than their White counterparts to receive shorter radiotherapy regimens, a study suggests.
Some patients do not understand common phrases oncologists use, such as “your tumor is progressing” or “your nodes are positive.”
Nivolumab plus ipilimumab did not prolong disease-free survival, and 43% of patients discontinued treatment due to toxicities.